linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet

RxCUI: 1243034
RxNorm name: linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet
Display name: linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet
Full name: linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Jentadueto	LINAGLIPTIN AND METFORMIN HYDROCHLORIDE	Boehringer Ingelheim Pharmaceuticals, Inc.	f6dd9b86-0d18-95d4-2bc7-05591bfdd597	2026-08-19	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1243034
Linagliptin and metformin hydrochloride	LINAGLIPTIN AND METFORMIN HYDROCHLORIDE	Novadoz Pharmaceuticals LLC	5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb	2025-11-04	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1243034

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f6dd9b86-0d18-95d4-2bc7-05591bfdd597	linagliptin 2.5 MG / metFORMIN HCl 850 MG Oral Tablet [PSN] · linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet [SCD]	2	45	These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. JENTADUETO ® (linagliptin and metformin hydrochloride tablets), for oral use Initial U.S. Approval: 2012	20240627
5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb	linagliptin 2.5 MG / metFORMIN HCl 850 MG Oral Tablet [PSN] · linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet [SCD]	2	1	These highlights do not include all the information needed to use LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS. LINAGLIPTIN and METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2012	20251104